GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cannabis Sativa Inc (OTCPK:CBDS) » Definitions » Debt-to-EBITDA

Cannabistiva (Cannabistiva) Debt-to-EBITDA : -0.25 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Cannabistiva Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cannabistiva's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.29 Mil. Cannabistiva's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. Cannabistiva's annualized EBITDA for the quarter that ended in Dec. 2023 was $-1.16 Mil. Cannabistiva's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.25.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Cannabistiva's Debt-to-EBITDA or its related term are showing as below:

CBDS' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.86   Med: -0.27   Max: 0
Current: -0.26

CBDS's Debt-to-EBITDA is ranked worse than
100% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs CBDS: -0.26

Cannabistiva Debt-to-EBITDA Historical Data

The historical data trend for Cannabistiva's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabistiva Debt-to-EBITDA Chart

Cannabistiva Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.86 -0.58 -0.28 -0.26

Cannabistiva Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.22 -0.35 -0.84 -0.25

Competitive Comparison of Cannabistiva's Debt-to-EBITDA

For the Health Information Services subindustry, Cannabistiva's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabistiva's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cannabistiva's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cannabistiva's Debt-to-EBITDA falls into.



Cannabistiva Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cannabistiva's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.29 + 0) / -1.115
=-0.26

Cannabistiva's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.29 + 0) / -1.16
=-0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Cannabistiva  (OTCPK:CBDS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Cannabistiva Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cannabistiva's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabistiva (Cannabistiva) Business Description

Traded in Other Exchanges
N/A
Address
450 Hillside Drive, Suite A224, Mesquite, NV, USA, 89027
Cannabis Sativa Inc along with its subsidiaries engages in the telemedicine business. It offers an online telemedicine platform providing customers access to knowledgeable physicians to obtain a medical marijuana recommendation.
Executives
Brad E Herr director, officer: Chief Financial Officer 5413 S SAYBROOK LANE, SPOKANE WA 99223
David Tobias director, 10 percent owner PO BOX 1602, MESQUITE NV 89024
Tankson Robert N. Iii director 6057 RYAN RANCH AVE, LAS VEGAS NV 89130
Donald Lundbom officer: CHIEF FINANCIAL OFFICER 37177 N WILD BARLEY PATH, SAN TAN VALLEY AZ 85140
Sadia P Barrameda 10 percent owner PO BOX 1363, DISCOVERY BAY CA 94505
Mike Gravel director 4467 OCEAN HEIGHTS CT,, SEASIDE CA 93955
Stephen Michael Downing director 152 LA VERNE AVENUE, LONG BEACH CA 90803
Debby Goldsberry director 1707 LEIMERT BLVD, OAKLAND CA 94607
Trevor S Reed director 20 BRAZOS TRAIL COURT, PLACITAS NM 87043
Catherine J Carroll director, officer: CFO and Treasurer 450 HILLSIDE DRIVE A224, MESQUITE NV 89027
James Polin Gray director 2531 CRESTVIEW DRIVE, NEWPORT BEACH CA 92663
Gary Earl Johnson director, officer: President, CEO & Secretary P.O. BOX 1858, EL PRADO NM 87529
Steve Kubby director, 10 percent owner, officer: Chairman of the Board 317 JUDITH'S FANCY, ST. CROIX VI 00823-5335
Barry Robert Tobias director 7305 DAMSEL LANE, FAIRVIEW TN 37062
Kirk Blosch 10 percent owner 2081 SOUTH LAKELINE DR, SALT LAKE CITY UT 84109